Verition Fund Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-282,376
| Closed | -$6.49M | – | 3301 |
|
|
2025
Q4 | $6.49M | Buy |
282,376
+258,856
| +1,101% | +$8.51M | 0.03% | 701 |
|
|
2025
Q3 | $707K | Sell |
23,520
-27,986
| -54% | -$839K | ﹤0.01% | 2798 |
|
|
2025
Q2 | $1.87M | Buy |
51,506
+4,474
| +10% | +$161K | 0.01% | 2009 |
|
|
2025
Q1 | $1.7M | Sell |
47,032
-238,009
| -83% | -$9.9M | 0.01% | 1691 |
|
|
2024
Q4 | $12M | Buy |
285,041
+207,735
| +269% | +$10.3M | 0.05% | 445 |
|
|
2024
Q3 | $4.29M | Sell |
77,306
-60,125
| -44% | -$3.06M | 0.02% | 956 |
|
|
2024
Q2 | $5.65M | Buy |
137,431
+21,506
| +19% | +$918K | 0.03% | 657 |
|
|
2024
Q1 | $5.41M | Buy |
115,925
+108,855
| +1,540% | +$5.13M | 0.04% | 617 |
|
|
2023
Q4 | $338K | Buy |
+7,070
| New | +$274K | ﹤0.01% | 1737 |
|
|
2023
Q3 | – | Sell |
-7,507
| Closed | -$346K | – | 2621 |
|
|
2023
Q2 | $346K | Buy |
7,507
+1,166
| +18% | +$54.1K | ﹤0.01% | 1456 |
|
|
2023
Q1 | $254K | Buy |
6,341
+1,294
| +26% | +$55.5K | ﹤0.01% | 1625 |
|
|
2022
Q4 | $234K | Sell |
5,047
-6,316
| -56% | -$248K | ﹤0.01% | 1647 |
|
|
2022
Q3 | $471K | Buy |
+11,363
| New | +$584K | 0.01% | 1936 |
|
|
2022
Q2 | – | Sell |
-89,483
| Closed | -$6.5M | – | 2932 |
|
|
2022
Q1 | $6.5M | Buy |
+89,483
| New | +$6.23M | 0.08% | 277 |
|
|
2021
Q3 | – | Sell |
-38,948
| Closed | -$3.71M | – | 2238 |
|
|
2021
Q2 | $3.71M | Buy |
+38,948
| New | +$4.06M | 0.03% | 309 |
|
|
2020
Q1 | – | Sell |
-15,793
| Closed | -$675K | – | 975 |
|
|
2019
Q4 | $675K | Buy |
+15,793
| New | +$652K | 0.01% | 570 |
|
|
2019
Q2 | – | Sell |
-9,378
| Closed | -$650K | – | 1316 |
|
|
2019
Q1 | $650K | Buy |
+9,378
| New | +$536K | 0.03% | 559 |
|
Other funds holding RARE
VPM
VCM
RI
SI
BG